Drug details

Tremfya (guselkumab for injection)

type of Monoclonal Antibodies, Antipsoriatics, Systemic, Interleukin Inhibitors

Tremfya (guselkumab) injection, for subcutaneous use is an interleukin-23 blocker indicated for the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

This drug may have the following side effects:

• diarrhea,
• joint pain,
• headache,
• injection site reactions,
• upper respiratory infections,
• gastroenteritis (nausea, vomiting, diarrhea, cramps, and fever),
• tinea infections (athlete's foot, ringworm, jock itch), and
  
• herpes simplex infections

The following drugs are related to Tremfya, either as a replacement or used together:

• Cibinqo (abrocitinib tablets)
• Bryhali (halobetasol propionate lotion)
• Wynzora (calcipotriene and betamethasone dipropionate cream)
• Sotyktu (deucravacitinib tablets)
• Kimyrsa (oritavancin for injeciton)
• Zoryve (roflumilast cream)
• Vtama (tapinarof cream)